News & Analysis
AI-powered market intelligence from WelthWest Research Desk. Original analysis, not just news.
351 articles · Page 9 of 30
June 2026 Market Outlook: Why Analysts are Pivoting to Penny Stocks and Technical Breakouts
Following a volatile end to May, the Indian equity landscape is witnessing a strategic rotation. While large-cap indices show signs of fatigue, specific technical setups in stocks like Rain Industries and IFCI suggest a massive liquidity migration toward value-oriented mid-caps and penny stocks for the June session.
Indian Market Outlook: Monsoon Inflation vs. Global Macro Tailwinds
The Indian equity landscape is currently caught in a tug-of-war between domestic climate risks and favorable international liquidity signals. While a potentially erratic monsoon threatens to keep food inflation sticky and the RBI hawkish, falling crude oil prices and easing US Treasury yields provide a significant margin cushion for heavy-weighted sectors like OMCs and Private Banks.
India Slashes Fuel Export Duties: Deep Dive into RIL, MRPL, and CPCL Gains
India's strategic decision to lower export duties on petrol, diesel, and ATF marks a pivot in energy policy. This deep dive explores why private refiners like Reliance Industries and state-owned players like MRPL are poised for a valuation rerating as tax burdens ease.
Delhi High Court Google Trademark Ruling: Why Indian Tech Stocks are Set to Surge
The Delhi High Court has delivered a landmark verdict holding Google liable for trademark infringement in its keyword advertising business. By preventing competitors from bidding on brand names, the court has fundamentally altered the unit economics of India's D2C and platform economy. This analysis explores why this is a bullish catalyst for major NSE-listed tech players.
PB Fintech Founders Exit: Is PolicyBazaar Stock a Buy After the Rs 665 Cr Sale?
PB Fintech founders Yashish Dahiya and Alok Bansal have offloaded a 0.8% stake in a massive Rs 665 crore block deal. While retail investors often fear founder exits, this transition to marquee institutional ownership signals a long-term bullish narrative for India's leading insurtech platform.
Happiest Minds Q4 Earnings: Why Mid-Cap IT is Winning the AI Arms Race
Happiest Minds reported a staggering 80% jump in net profit, fueled by aggressive Generative AI integration. This performance highlights a critical pivot in the Indian IT sector: the rise of agile, mid-cap firms over legacy giants in the race to monetize AI.
Asian Paints Q4 Results: Is the 12.4% Volume Surge a Bull Market Signal?
Asian Paints’ Q4 FY26 performance has shattered bearish expectations with a 12.4% volume surge and a 69% net profit jump. We analyze the implications for the Indian building materials sector and what this means for your portfolio.
NTA’s ₹5,000 Crore Digital Pivot: Top Stocks to Buy as NEET Shifts to CBT
Following the NEET-UG 2024 integrity crisis, the National Testing Agency (NTA) is pivoting toward a massive digital overhaul involving AI-proctoring and CBT. This investigative report breaks down the ₹5,000 crore addressable market, identifying the specific NSE-listed stocks positioned to capture this transition and the risks inherent in India's rural digital divide.
Indian Market Rotation: Why IT Giants Are Faltering vs Domestic Champions
Q3 performance data reveals a stark divergence in the Nifty 50. While global IT spending fatigue drags down large-cap tech, domestic demand-driven sectors are capturing record inflows. This article analyzes the winners, losers, and the shifting macro-narrative defining the current Indian market cycle.
Nifty 50 Sectoral Rotation: Why Smart Money is Moving from FMCG to Pharma Stocks
While the headline Nifty 50 index remains resilient, a significant internal churn is redefining the Indian market's leadership. This comprehensive analysis explores why defensive sectors like Pharma are outperforming while traditional consumption giants like HUL and UPL face structural headwinds.
Q4 Earnings Reality Check: Why Defence and FMCG Stocks Are Facing a Correction
Recent Q4 results from Bharat Dynamics and P&G Hygiene reveal deep-seated cracks in the Indian market’s two most resilient sectors. With profit contraction in defence and stagnant consumption in staples, the market is bracing for a period of valuation recalibration. We analyze the underlying data and what this means for your portfolio.
Cipla Stock Volatility: Decoding Indian Pharma's Next Big Move
Recent volatility in Cipla's share price has sparked renewed interest in the trajectory of India's pharmaceutical giants. Our in-depth analysis at WelthWest Research Desk uncovers the underlying drivers, potential market ripple effects, and actionable strategies for navigating this evolving landscape. This isn't just about one stock; it's a bellwether for the entire Indian pharma narrative.